Jae‐Sook Ahn

2.5k total citations
132 papers, 1.4k citations indexed

About

Jae‐Sook Ahn is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Jae‐Sook Ahn has authored 132 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hematology, 40 papers in Oncology and 37 papers in Genetics. Recurrent topics in Jae‐Sook Ahn's work include Acute Myeloid Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (30 papers) and Multiple Myeloma Research and Treatments (29 papers). Jae‐Sook Ahn is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (30 papers) and Multiple Myeloma Research and Treatments (29 papers). Jae‐Sook Ahn collaborates with scholars based in South Korea, Canada and United States. Jae‐Sook Ahn's co-authors include Je‐Jung Lee, Hyeoung‐Joon Kim, Sung‐Hoon Jung, Deok‐Hwan Yang, Deok‐Hwan Yang, Yeo‐Kyeoung Kim, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Myung‐Geun Shin and Joon Ho Moon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jae‐Sook Ahn

123 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jae‐Sook Ahn South Korea 21 647 454 374 373 221 132 1.4k
Deok‐Hwan Yang South Korea 20 488 0.8× 437 1.0× 256 0.7× 386 1.0× 169 0.8× 124 1.3k
Deok‐Hwan Yang South Korea 22 455 0.7× 727 1.6× 397 1.1× 688 1.8× 252 1.1× 112 1.6k
Ho‐Jin Shin South Korea 22 944 1.5× 655 1.4× 399 1.1× 691 1.9× 365 1.7× 182 2.0k
Vito Michele Lauta Italy 13 498 0.8× 586 1.3× 319 0.9× 312 0.8× 212 1.0× 24 1.1k
Akihiko Yokohama Japan 19 594 0.9× 379 0.8× 333 0.9× 361 1.0× 272 1.2× 135 1.9k
Taiga Nishihori United States 22 984 1.5× 751 1.7× 390 1.0× 235 0.6× 231 1.0× 169 1.7k
Yeo‐Kyeoung Kim South Korea 20 675 1.0× 261 0.6× 412 1.1× 131 0.4× 253 1.1× 91 1.2k
JL Harousseau France 19 895 1.4× 675 1.5× 594 1.6× 277 0.7× 215 1.0× 24 1.4k
Kazutaka Sunami Japan 18 667 1.0× 530 1.2× 368 1.0× 293 0.8× 222 1.0× 115 1.2k
A Grañena Spain 22 846 1.3× 426 0.9× 250 0.7× 359 1.0× 325 1.5× 86 1.6k

Countries citing papers authored by Jae‐Sook Ahn

Since Specialization
Citations

This map shows the geographic impact of Jae‐Sook Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae‐Sook Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae‐Sook Ahn more than expected).

Fields of papers citing papers by Jae‐Sook Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae‐Sook Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae‐Sook Ahn. The network helps show where Jae‐Sook Ahn may publish in the future.

Co-authorship network of co-authors of Jae‐Sook Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Jae‐Sook Ahn. A scholar is included among the top collaborators of Jae‐Sook Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae‐Sook Ahn. Jae‐Sook Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Soo‐Kyung, Jaeeun Yoo, Jae‐Sook Ahn, et al.. (2025). Current practices in peripheral blood stem cell processing and cryopreservation: a nationwide survey of Korean transplant centers. Blood Research. 60(1). 41–41.
2.
Song, Ga‐Young, Seo-Yeon Ahn, Sung‐Hoon Jung, et al.. (2025). Prognostic Value of 18F-FDG PET in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. 50(4). 281–288. 1 indexed citations
3.
Vo, Manh-Cuong, Sunghoon Jung, Xuan‐Hung Nguyen, et al.. (2024). Exploring cellular immunotherapy platforms in multiple myeloma. Heliyon. 10(6). e27892–e27892. 2 indexed citations
4.
Baek, Dong Won, Han‐Seung Park, Sang Kyun Sohn, et al.. (2023). Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. The Korean Journal of Internal Medicine. 38(5). 734–746. 5 indexed citations
5.
Kim, Hyeoung‐Joon, et al.. (2023). Identification of Cell Type-Specific Effects of DNMT3A Mutations on Relapse in Acute Myeloid Leukemia. Molecules and Cells. 46(10). 611–626. 5 indexed citations
6.
Kim, Tae‐Hyung, Mihee Kim, Ga‐Young Song, et al.. (2023). Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia. Cancer Research and Treatment. 55(3). 1011–1022. 3 indexed citations
7.
Ahn, Jae‐Sook, Jina Yun, Sung Hee Lim, et al.. (2023). Clinical Experience of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients Aged 60 Years and Older in South Korea. Yonsei Medical Journal. 64(2). 123–123.
8.
Vo, Manh-Cuong, Seo-Yeon Ahn, Mihee Kim, et al.. (2022). Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. Translational Oncology. 20. 101413–101413. 6 indexed citations
9.
Byun, Ja Min, Hyeong Joon Kim, Jae‐Sook Ahn, et al.. (2022). IDH1/2 mutations in acute myeloid leukemia. Blood Research. 57(1). 13–19. 15 indexed citations
10.
Cho, Hee Jeong, Dong Won Baek, Ju-Hyung Kim, et al.. (2021). Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline. Clinical Lymphoma Myeloma & Leukemia. 22(2). 113–120. 1 indexed citations
11.
Moon, Jeong Mi, et al.. (2021). Coagulopathy after snake envenomation in South Korea. Clinical Toxicology. 59(10). 905–912. 7 indexed citations
12.
Park, Sungwoo, Dong Won Baek, Sang Kyun Sohn, et al.. (2019). Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 19(7). e367–e373. 2 indexed citations
13.
Lee, Yoo Jin, Dong Won Baek, Jae‐Sook Ahn, et al.. (2018). Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission. Clinical Lymphoma Myeloma & Leukemia. 18(12). e529–e535. 2 indexed citations
14.
15.
16.
Jung, Sung‐Hoon, Jae‐Sook Ahn, Yeo-Kyeoung Kim, et al.. (2016). Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients. Journal of Korean Medical Science. 31(7). 1160–1160. 7 indexed citations
17.
Jung, Sung‐Hoon, Hee Kyung Kim, Ho‐Cheol Kang, et al.. (2016). Secondary Adrenal Insufficiency Is Associated with Poor Survival Outcomes in Multiple Myeloma. Blood. 128(22). 5631–5631. 1 indexed citations
18.
Jung, Sung‐Hoon, Jae‐Sook Ahn, Deok‐Hwan Yang, et al.. (2015). Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment. Blood Research. 50(3). 167–167. 1 indexed citations
19.
Ahn, Jae‐Sook, Deok‐Hwan Yang, Sung‐Hoon Jung, et al.. (2012). A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma. Annals of Hematology. 91(7). 1023–1030. 12 indexed citations
20.
Kim, Yeo-Kyeoung, Hee Nam Kim, Jae‐Sook Ahn, et al.. (2011). Treatment outcome of all- trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3 /ITD mutation in acute promyelocytic leukemia patients. The Korean Journal of Hematology. 46(1). 24–24. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deok‐Hwan Yang Breakdown of academic impact, for papers by Deok‐Hwan Yang Breakdown of academic impact, for papers by Ho‐Jin Shin Breakdown of academic impact, for papers by Vito Michele Lauta Breakdown of academic impact, for papers by Akihiko Yokohama Breakdown of academic impact, for papers by Taiga Nishihori Breakdown of academic impact, for papers by Yeo‐Kyeoung Kim Breakdown of academic impact, for papers by JL Harousseau Breakdown of academic impact, for papers by Kazutaka Sunami Breakdown of academic impact, for papers by A Grañena
Rankless by CCL
2026